Luiz H. Araujo

Papers

Total Citations

H-Index

About

Luiz H. Araujo is a distinguished oncologist and translational researcher whose work centers on lung cancer biology, immunotherapy, and precision oncology. His major contributions include advancing the understanding of molecular mechanisms driving non-small cell lung cancer (NSCLC) and identifying biomarkers that predict response to immune checkpoint inhibitors. Notably, his highly cited 2020 review, "Cancer of the Lung," synthesizes critical insights into tumor heterogeneity, treatment resistance, and emerging therapeutic strategies, earning 42 citations and serving as a foundational resource for clinicians and researchers. Araujo’s research has directly influenced clinical trial design and patient stratification, bridging the gap between laboratory discoveries and bedside applications. His impact is reflected in a growing body of work that has shaped guidelines for lung cancer management, particularly in immunotherapy combinations and targeted therapies. Beyond his publications, Araujo is recognized for his mentorship of early-career scientists and his leadership in collaborative international studies. For students and researchers, his profile exemplifies how rigorous translational science can transform the landscape of thoracic oncology, offering a roadmap for integrating molecular insights into personalized cancer care.